[Neuron-specific enolase (NSE) serum level as a prognostic factor in non-small cell lung cancer].

The aim of the study was to assess the significance of elevated NSE serum level in NSCLC patients for tumor response to chemotherapy and for survival. The NSE serum level above 12.5 mg/l was regarded as elevated.